{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-016848","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2021-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.325371+00:00","generated_at":"2026-06-30T05:37:47.441097+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"LeMaitre Q2 net sales $40.7M (+64%), op income up ~128%; launches stock offering, receives CE marks","bullets":["Q2 preliminary net sales $40.7M (+64% reported, +35% organic vs Q2 2020).","Operating income ~$10.9-11.3M, up ~128% at midpoint vs Q2 2020.","Gross margin 65.5-66.1%, down 2.7pp at midpoint due to inventory write-downs and manufacturing inefficiencies.","Commenced underwritten public offering of common stock; proceeds to repay $23M debt and for general corporate purposes.","Received renewed CE marks for five vascular products expiring 2024; XenoSure indications narrowed (no neuro/cardiac)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-016848","json":"https://secwatch.observer/filing/0001437749-21-016848.json","markdown":"https://secwatch.observer/filing/0001437749-21-016848.md","text":"https://secwatch.observer/filing/0001437749-21-016848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921016848/0001437749-21-016848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921016848/lmat20210712_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:37:47.441097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}